IPO registrations (S-1, F-1) · Registrants

KOS PHARMACEUTICALS INC

SEC CIK
1018952 · filings on EDGAR ↗
Registration
Form S-1, first filed 1996-12-17, last 1997-10-20; 2 initial registrations, 6 amendments
Outcome
Final prospectus filed 1997-03-07
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
FL
Business address
1 CEDAR BROOK DRIVE, Cranbury, NJ 08512
EIN
65-0670898
EDGAR entity type
operating
Insiders and CEO pay
KOS PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 1997-03-06)
Final price
$15.00 per share, within the range (424B4 filed 1997-03-07, an initial public offering)
Shares sold
4,150,000
Gross proceeds
$62,250,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol KOSP
Lead underwriters
Cowen (856,000 shares)
Syndicate
Citigroup (856,000); Dillon, Read & Co. Inc (856,000); Bear Stearns (83,000); Alex. Brown & Sons (83,000); Credit Suisse (83,000); Donaldson, Lufkin & Jenrette (83,000); Hambrecht & Quist (83,000); Lazard (83,000); Lehman Brothers (83,000); Morgan Stanley (83,000); Oppenheimer (83,000); PaineWebber (83,000); Prudential Securities (83,000); Schroder Wertheim & Co. Incorporated (83,000); UBS (83,000); Invemed Associates, Inc (83,000); Allen & Company (42,000); Brean Murray & Co., Inc (42,000); Furman Selz LLC (42,000); Genesis Merchant Group Securities (42,000); Gruntal & Co., Incorporated (42,000); Nesbitt Burns Securities Inc (42,000); Raymond James (42,000); Scott & Stringfellow, Inc (42,000); Vector Securities International, Inc (42,000); Volpe, Welty & Company LLC (42,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
1996-12-17S-1S-1 (registration)KOS PHARMACEUTICALS INC0000950170-96-001109 ↗
1997-01-17S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950170-97-000028 ↗
1997-02-10S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950170-97-000106 ↗
1997-03-06S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950170-97-000259 ↗
1997-03-06S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950170-97-000265 ↗
1997-03-07S-1MEFS-1MEF (added securities)KOS PHARMACEUTICALS INC0000950170-97-000266 ↗
1997-03-07424B4424B4 (final prospectus)KOS PHARMACEUTICALS INC0000950170-97-000269 ↗
1997-09-11S-1S-1 (registration)KOS PHARMACEUTICALS INC0000950144-97-009965 ↗
1997-09-25S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950144-97-010368 ↗
1997-10-20S-1/AS-1/A (amendment)KOS PHARMACEUTICALS INC0000950144-97-011049 ↗
1997-10-22424B1424B1 (final prospectus)KOS PHARMACEUTICALS INC0000950144-97-011092 ↗

Prospectus pages read 3

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1997-03-06S-1/Aregistration statement$13.00–$15.003,500,000-Nasdaq KOSP3from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3document ↗
1997-03-06S-1/Aregistration statement--0from the submission text; no terms founddocument ↗
1997-03-07424B4final prospectus$15.004,150,000$62,250,000Nasdaq KOSP27from the submission text; price sentence, shares general, proceeds computed, underwriting table 27, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
KING RICHARDOfficerEVP, Commercial Operations52006
ADAMS ADRIANDirector,OfficerPresident & CEO32006
BALDINI ROBERT EDirector52006
BELL DANIEL MDirector22006
KOVEN ANDREW IOfficerEVP, General Counsel22006
MCGOVERN MARK EOfficerEVP, Chief Medical Officer32006
RODRIGUEZ JUAN FOfficerSVP, Controller & Corp. Admin.42006
ROSSKAMP RALFOfficerEVP, Research and Development42006
JAHARIS MARYTenPercentOwner82006
JAHARIS MICHAELDirector,TenPercentOwner82006
BRADEMAS JOHNDirector22006
Ferro KevinDirector32006
JAHARIS STEVENDirector; Director,TenPercentOwner32006
NOVITCH MARK M DDirector32006
Pruitt William DDirector22006
WHITTEMORE FREDERICK BDirector22006
Jaharis Family Foundation, Inc.TenPercentOwner22006
Steven Jaharis Generational TrustTenPercentOwner22006
MADIAS NICHOLAOS EDirector22006
Clarke Kevin POfficerEVP, Chief Financial Officer12006
CUBS MANAGEMENT LLCTenPercentOwner12006
Jaharis Holdings, LLCTenPercentOwner12006
JAHARIS KATHRYNTenPercentOwner12006
WILSON POINT HOLDINGS LPTenPercentOwner12006

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationKOS PHARMACEUTICALS, INC.ILState business registriesEIN (EXACT, as the state registration reports it)
Lobbying clientKOS PHARMACEUTICALSNJFederal lobbying (LDA)name and state
Lobbying clientKOS PHARMACEUTICALS INCNJFederal lobbying (LDA)name and state
Lobbying registrantKOS PHARMACEUTICALS INCNJFederal lobbying (LDA)name and state
SEC filerKOS PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerKos Pharmaceuticals, Inc.NJTrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health